Redigerer Noora (vaksine)

'''Noora''' ({{lang-fa|نورا}}) er en [[covid-19-vaksine]]kandidat utviklet av [[Baqiyatallah-universitetet for medisinvitenskaper]] i [[Teheran]] i [[Iran]].<ref>{{cite news |title=IRGC starts clinical trial of "Noora" coronavirus vaccine |url=https://www.tehrantimes.com/news/462470/IRGC-starts-clinical-trial-of-Noora-coronavirus-vaccine |access-date=1. juli 2021 |publisher=Tehran Times |date=27. juni 2021}}</ref><ref>{{cite news |title=IRGC Commander: Iran-Made 'Noora' Coronavirus Vaccine Ready for 2nd Stage of Human Trial |url=https://www.farsnews.ir/en/news/14000531000599/IRGC-Cmmander-Iran-Made-%E2%80%98Nra%E2%80%99-Crnavirs-Vaccine-Ready-fr-2nd-Sage-f |access-date=30. august 2021 |agency=Fars News Agency |date=22. august 2021}}</ref>

Den administeres i tre doser ved [[intramuskulær injeksjon]] på dagene 0, 21 og 35.<ref name=":0" />

Noora er en rekombinant RBD protein[[subenhet]]-vaksine.<ref name=":0">{{Cite web| |title=A randomized, double-blinded, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of three dose regimens of COVID-19 RBD protein recombinant vaccine (AmitisGen; 80µg and 120µg) in a healthy population |url=https://www.irct.ir/trial/56987 |website=Iranian Clinical Trials Registry |date=25. juni 2021 |id=IRCT20210620051639N1 |access-date=1. juli 2021 }}</ref>

Per 8. desember 2021 er det blitt produsert fem millioner doser.<ref>{{Cite web|title=5 میلیون دوز واکسن &quot;نورا&quot; تولید شد- اخبار پزشکی - اخبار اجتماعی تسنیم {{!}} Tasnim|url=https://www.tasnimnews.com/fa/news/1400/09/17/2622286/5-%D9%85%DB%8C%D9%84%DB%8C%D9%88%D9%86-%D8%AF%D9%88%D8%B2-%D9%88%D8%A7%DA%A9%D8%B3%D9%86-%D9%86%D9%88%D8%B1%D8%A7-%D8%AA%D9%88%D9%84%DB%8C%D8%AF-%D8%B4%D8%AF|access-date=2021-12-08|website=خبرگزاری تسنیم {{!}} Tasnim|language=fa}}</ref>

== Referanser ==
<references />

{{Autoritetsdata}}

[[Kategori:Koronavirus vaksinearbeid]]
[[Kategori:Covid-19-vaksiner]]
[[Kategori:Iran]]